Portfolio Lab

Varex Imaging Corp

  • Stock
  • Ticker VREX
  • ISIN US92214X1063
  • Nasdaq

Technology · Semiconductors and electronic components · USA

$18.10 −0.22%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of Varex Imaging Corp since 01/2017, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

VREXGlobal equities (VT)

$10,000 grew to $6,430. Global equities (VT): $27,843.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −84.2% in 05/2025, measured from the peak in 02/2018. The old peak has not been reached again yet.

1-year return
+75.9%
5-year return p.a.
−9.3%
Return p.a. since 01/2017
−4.4%
Volatility p.a.
47.8%
Largest decline
−84.2%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end09/202401/202504/202507/202510/202501/202604/202607/2026
Income statement
Revenue206200213203229210216211
Gross profit6769776878707377
Operating income111122-8120151423
EBITDA171728-7525212029
Net income-51-0.36.9-89122.3-8.116
Earnings per share-1.26-0.010.17-2.150.300.05-0.190.37
Balance sheet
Total assets1,2141,3321,3581,0731,1071,0981,0891,100
Liabilities670778794604621607601590
Equity529540550455473477474497
Cash1691762051361451208599
Long-term debt397566566366366366329329
Cash flow
Operating cash flow269.5177.77.9-16-1.521
Capital expenditure-6.0-4.2-6.8-6.3-5.6-11-6.2-9.0
Free cash flow205.39.81.42.3-27-7.712

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2021 at +89.1%, weakest 2020 at −44.0%. 3 of 8 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
10 Aug 2026$0.37
7 May 2026−$0.19
10 Feb 2026$0.05
18 Nov 2025$0.30
7 Aug 2025−$2.15
8 May 2025$0.17
6 Feb 2025−$0.01
19 Nov 2024−$1.26
1 Aug 2024$0.03
2 May 2024$0.03
6 Feb 2024−$0.01
16 Nov 2023$0.67

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€691m
Market cap in trading currency
$762m
Enterprise value
$1.01bn
P/E
34.2
P/S
0.88
P/B
1.53
EV/Sales
1.17
EV/EBITDA
10.6
Earnings yield
2.9%
FCF yield
-2.7%

Results (last four quarters)

Revenue
$865m
Gross profit
$297m
EBITDA
$95.1m
Net income
$22.1m
Earnings per share
$0.53
Revenue per share
$20.55
Revenue growth
+3.7%
Earnings growth
–

Profitability

Gross margin
34.3%
Operating margin
8.3%
Net margin
2.6%
Return on equity
4.6%
Return on assets
2.0%

Balance sheet and cash flow

Cash
$99.2m
Cash per share
$2.36
Financial debt
$347m
Debt/equity %
70
Current ratio
3.38
Book value per share
$11.80
Operating cash flow
$11.3m
Free cash flow
−$20.2m

Dividend

Dividend yield
0.00%
Dividend (12 months)
$0.00
Yield (12 months)
0.00%
Payout ratio
0%
Ex-dividend date
–

Shares and trading

Shares outstanding
42.1m
Volume
620,444
Avg. volume 3 months
635,662
Relative volume
1.0

Price and technicals

Price
$18.10
1 day
−0.2%
52-week high
$18.58
52-week low
$9.32
Distance to 52-week high
−2.6%
Distance to 52-week low
+94.2%
Distance to 50-day line
−1.7%
Distance to 200-day line
+30.0%
RSI (14)
33
Volatility 1M
4.9%

Performance

1 week
0.0%
1 month
−1.7%
3 months
−2.3%
6 months
+79.7%
YTD
+55.4%
1 year
+76.8%

Dates

Fiscal year end
3 Oct 2025
Most recent quarter
3 Jul 2026

Frequently asked questions

How has VREX performed since 01/2017?

$10,000 grew to $6,430 by 20 Nov 2026, which is −4.4% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is VREX?

Volatility was 47.8% per year, measured on monthly returns. The largest decline from a peak was −84.2%, with the low in 05/2025.

How does VREX compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.0% per year at 15.2% volatility, VREX returned −4.4% at 47.8%. The correlation of monthly returns was 0.32; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Varex Imaging Corp (VREX): Return and risk | Portfolio Lab